Open an account

Bioqual

BIOQ · OTC

$33.00+$32.50 (+6500.00%)TodayMarket closed ·
No price history for this range.

About BIOQ

Bioqual, Inc. engages in the provision and development of medical research and consulting services to commercial clients and government laboratories. The company is headquartered in Rockville, Maryland. The company also performs in vitro contract research services. The company is involved in the evaluation of vaccines, vaccine therapeutics, microbicides, and drug therapies. Its services also encompass sample processing and custom assays for serology, cell-mediated immunity, viral loads, and bacterial enumeration. Its additional services include advanced biocontainment (BSL3), imaging services, animal model development, and IND-enabling services. Its lab services include cell-based assays, immunoassays, toxicity and cytotoxicity testing, viral load testing, and tailored assay development.

Employees
0
Headquarters
Rockville, Maryland
Listed
Jul 14, 1983
Sector
Health Care
Industry
Biotechnology
Website
bioqual.com

BIOQ key statistics

Market cap
29.50M
Price-earnings ratio
—
Dividend yield
—
Average volume
560
Volume
50
Open price
$33.00
High today
$33.00
Low today
$33.00
52 Week high
$38.51
52 Week low
$32.50

Bioqual (BIOQ) at a glance

Bioqual (BIOQ) last traded at $33.00, with a market cap of 29.50M.

Volume so far is 50 shares, below the average of 560 shares a day.

Over the past year Bioqual has ranged from $32.50 to $38.51, and now sits 8% of the way up that range.

Bioqual met or beat analyst EPS estimates in 2 of the last 3 quarters. In Q1 FY25 it reported -$0.76 per share against an estimate of $0.00.

BIOQ earnings

Earnings per share, reported against the analyst estimate

Beat the estimate in 2 of the last 3 quarters, by 0.0% on average.

  1. Q2 FY23: reported $1.45 per share against an estimate of $0.00
  2. Q2 FY24: reported $0.54 per share against an estimate of $0.00
  3. Q1 FY25: reported -$0.76 per share against an estimate of $0.00

BIOQ news

  • Press releaseBusiness Wire

    BIOQUAL Presents Financial Results for Fiscal Year 2025

  • Press releaseBusiness Wire

    BIOQUAL Announces the retirement of Dr. Mark G. Lewis as President and CEO of the company

  • Press releaseBusiness Wire

    BIOQUAL Announces Retirement of Mike O'Flaherty From Board

  • Press releaseBusiness Wire

    BIOQUAL Presents Unaudited Financial Results for Third Quarter of Fiscal Year 2025

  • Press releaseBusiness Wire

    BIOQUAL Presents Unaudited Financial Results for Second Quarter of Fiscal Year 2025

  • Press releaseBusiness Wire

    BIOQUAL Announces Changes to Board of Directors

  • Press releaseBusiness Wire

    BIOQUAL Presents Unaudited Financial Results for First Quarter of Fiscal Year 2025

  • Press releaseBusiness Wire

    BIOQUAL Declares Dividend

Similar companies

Companies in the same industry as Bioqual

Most active stocks

Highest trading volume today

Newly listed

Companies that went public in the past six weeks

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.